D
Denise Robinson
Researcher at International Life Sciences Institute
Publications - 13
Citations - 2676
Denise Robinson is an academic researcher from International Life Sciences Institute. The author has contributed to research in topics: Risk assessment & Toxicity. The author has an hindex of 11, co-authored 13 publications receiving 2481 citations.
Papers
More filters
Journal ArticleDOI
Concordance of the toxicity of pharmaceuticals in humans and in animals.
Harry Olson,Graham Betton,Denise Robinson,Karluss Thomas,A.M. Monro,Gerald Kolaja,Patrick D. Lilly,James E. Sanders,Glenn Sipes,William Bracken,Michael A. Dorato,Koen Van Deun,Peter Smith,Bruce Berger,Allen H. Heller +14 more
TL;DR: The survey results support the value of in vivo toxicology studies to predict for many significant HTs associated with pharmaceuticals and have helped to identify HT categories that may benefit from improved methods.
Journal ArticleDOI
Evolution of Science-Based Uncertainty Factors in Noncancer Risk Assessment
TL;DR: The results of this review support the use of data-derived uncertainty factors when appropriate scientific data are available and incorporation of all available scientific data into the risk assessment process fosters increased research and ultimately reduces uncertainty.
Journal ArticleDOI
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans
Russell C. Cattley,John G. DeLuca,Cliff Elcombe,Penelope A. Fenner-Crisp,Brian G. Lake,Daniel S. Marsman,Timothy A. Pastoor,James A. Popp,Denise Robinson,Bernard A. Schwetz,Jonathan Tugwood,Walter Wahli +11 more
TL;DR: Consensus was reached regarding the significant intermediary roles of cell proliferation and PPAR-alpha receptor expression and activation in tumor formation and risk assessments based on tumor data may not be appropriate.
Journal ArticleDOI
Background and Framework for ILSI's Collaborative Evaluation Program on Alternative Models for Carcinogenicity Assessment
TL;DR: A large-scale collaborative research program to help to better characterize the responsiveness of several models proposed for use in carcinogenicity assessment and the database from these studies represents an important contribution to the future application of new models for human cancer risk assessment.
Journal ArticleDOI
Chloroform mode of action : Implications for cancer risk assessment
TL;DR: The weight of the scientific evidence concerning chloroform-induced tumors in rodents is consistent with and supports a cancer risk assessment methodology based on mode of action as the basis for establishing regulatory standards for this compound.